Chemed Cash on Hand 2012-2026 | CHE
Chemed cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Chemed cash on hand for the quarter ending June 30, 2026 was $0.040B, a 83.91% decline year-over-year.
- Chemed cash on hand for 2025 was $0.075B, a 58.22% decline from 2024.
- Chemed cash on hand for 2024 was $0.178B, a 32.43% decline from 2023.
- Chemed cash on hand for 2023 was $0.264B, a 256.09% increase from 2022.
|
Chemed Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $75 |
| 2024 | $178 |
| 2023 | $264 |
| 2022 | $74 |
| 2021 | $33 |
| 2020 | $163 |
| 2019 | $6 |
| 2018 | $5 |
| 2017 | $11 |
| 2016 | $15 |
| 2015 | $15 |
| 2014 | $14 |
| 2013 | $84 |
| 2012 | $70 |
| 2011 | $38 |
|
Chemed Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $40 |
| 2026-03-31 | $17 |
| 2025-12-31 | $75 |
| 2025-09-30 | $130 |
| 2025-06-30 | $250 |
| 2025-03-31 | $174 |
| 2024-12-31 | $178 |
| 2024-09-30 | $238 |
| 2024-06-30 | $223 |
| 2024-03-31 | $313 |
| 2023-12-31 | $264 |
| 2023-09-30 | $173 |
| 2023-06-30 | $160 |
| 2023-03-31 | $58 |
| 2022-12-31 | $74 |
| 2022-09-30 | $8 |
| 2022-06-30 | $10 |
| 2022-03-31 | $18 |
| 2021-12-31 | $33 |
| 2021-09-30 | $29 |
| 2021-06-30 | $92 |
| 2021-03-31 | $210 |
| 2020-12-31 | $163 |
| 2020-09-30 | $113 |
| 2020-06-30 | $20 |
| 2020-03-31 | $29 |
| 2019-12-31 | $6 |
| 2019-09-30 | $9 |
| 2019-06-30 | $3 |
| 2019-03-31 | $9 |
| 2018-12-31 | $5 |
| 2018-09-30 | $67 |
| 2018-06-30 | $13 |
| 2018-03-31 | $14 |
| 2017-12-31 | $11 |
| 2017-09-30 | $19 |
| 2017-06-30 | $14 |
| 2017-03-31 | $47 |
| 2016-12-31 | $15 |
| 2016-09-30 | $21 |
| 2016-06-30 | $17 |
| 2016-03-31 | $15 |
| 2015-12-31 | $15 |
| 2015-09-30 | $38 |
| 2015-06-30 | $33 |
| 2015-03-31 | $28 |
| 2014-12-31 | $14 |
| 2014-09-30 | $19 |
| 2014-06-30 | $28 |
| 2014-03-31 | $39 |
| 2013-12-31 | $84 |
| 2013-09-30 | $83 |
| 2013-06-30 | $113 |
| 2013-03-31 | $73 |
| 2012-12-31 | $70 |
| 2012-09-30 | $69 |
| 2012-06-30 | $60 |
| 2012-03-31 | $34 |
| 2011-12-31 | $38 |
| 2011-09-30 | $21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $6.665B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.874B | 13.39 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.368B | 15.15 |
| Encompass Health (EHC) | United States | $12.224B | 21.22 |
| Elanco Animal Health (ELAN) | United States | $11.421B | 21.57 |
| RadNet (RDNT) | United States | $5.964B | 172.23 |
| LifeStance Health (LFST) | United States | $4.888B | 98.39 |
| Option Care Health (OPCH) | United States | $3.665B | 15.49 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.112B | 21.61 |
| Addus HomeCare (ADUS) | United States | $2.213B | 20.02 |
| Astrana Health (ASTH) | United States | $2.101B | 22.31 |
| Pennant (PNTG) | United States | $1.484B | 38.62 |
| U.S Physical Therapy (USPH) | United States | $1.244B | 32.83 |
| Daxor (DXR) | United States | $0.068B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |